Senior insider sale
Chief Medical Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$503.0K
21.24K shares
What this filing means
WELGUS HOWARD G. plans to sell 21.24K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $503.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/15/2026ACC: 0001628280-26-043178
Officer· Chief Medical Officer
Since Jan 2020
21.24K
Shares to sell
$503.0K
Approx. market value
4.10K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months3
Stock Option Exercise
Cash
6/14/2024
2.25KStock Option Exercise
Cash
5/31/2023
1.02KStock Option Exercise
Cash
11/20/2019
822.00Total acquired4.10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/14/2024 | Stock Option Exercise Cash | 2.25K | — |
5/31/2023 | Stock Option Exercise Cash | 1.02K | — |
11/20/2019 | Stock Option Exercise Cash | 822.00 | — |
| Total | 4.10K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
7.14K
Market value
$164.2K
5/1/2026
—Completed
Units to sell
10K
Market value
$238.8K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.10K
Market value
$100.0K
6/15/2026
Total
Units
21.24K
Value
$503.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/1/2026 | 7.14K | $164.2K | — | Completed |
4/1/2026 | 10K | $238.8K | — | Completed |
| Planned — Approximate Date | ||||
6/15/2026 | 4.10K | $100.0K | NASDAQ | Planned |
| Total | 21.24K | $503.0K | ||